PRIA Logo™
119-hr-10887119th Congress

Protecting Consumer Access to Generic Drugs Act of 2026

Sponsored By: Representative Magaziner, Seth [D-RI-2]

Introduced

Summary

Bans pay-for-delay deals that keep generics and biosimilars off the market. This bill would prohibit settlements where a generic or biosimilar applicant receives value in exchange for limiting or delaying research, manufacturing, marketing, or sales tied to resolution of a patent infringement claim.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & CoSponsors

Sponsor

Magaziner, Seth [D-RI-2]

RI • D

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation